celiprolol has been researched along with cyclic gmp in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kitazawa, S; Ma, FH; Noda, K; Oka, M; Toda, N; Ukai, Y | 1 |
Akaishi, Y; Hattori, Y; Kitabatake, A; Sakuma, I; Sato, A; Tomioka, H | 1 |
2 other study(ies) available for celiprolol and cyclic gmp
Article | Year |
---|---|
Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Celiprolol; Coronary Vessels; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Superoxide Dismutase; Swine; Vasodilation | 2001 |
Interactions of sildenafil with various coronary vasodilators in isolated porcine coronary artery.
Topics: Animals; Celiprolol; Coronary Vessels; Cyclic GMP; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; In Vitro Techniques; Nicorandil; Nitroprusside; Pinacidil; Piperazines; Propanolamines; Purines; Sildenafil Citrate; Sulfones; Swine; Vasodilation; Vasodilator Agents | 2002 |